The Taxus drug-eluting stent: a new paradigm in controlled drug delivery

Advanced Drug Delivery Reviews
Kalpana R KamathKathleen M Miller

Abstract

The advent of drug-eluting stents (DES) has provided the medical community with a technology that is transforming the treatment of coronary artery disease. As the newest treatment modality available to the interventional cardiologist, drug-eluting stents have not only significantly reduced the risk of restenosis, but they are also allowing the interventionalists to treat more complex lesions in patients that would otherwise require more invasive bypass surgery. Development of these drug-device combination products has presented considerable challenges to the device industry because it involves a multi-disciplinary approach that combines conventional device design and manufacturing with the principles of controlled local drug delivery. This review article provides an in-depth discussion of the key elements of drug-eluting stents, focusing on the TAXUS paclitaxel-eluting stent as an example of this new class of product. Specific sections will review the drug and polymer matrix components, formulation development and evaluation, pre-clinical studies and clinical trial results.

References

Feb 22, 1979·Nature·P B SchiffS B Horwitz
Apr 1, 1992·Journal of Natural Products·G N ChmurnyJ A Beutler
Apr 1, 1995·The Journal of Clinical Investigation·S J SollottE K Rowinsky
Oct 1, 1994·Journal of Pharmaceutical Sciences·S V BalasubramanianR M Straubinger
Apr 13, 1995·The New England Journal of Medicine·E K Rowinsky, R C Donehower
Oct 1, 1995·Journal of Pharmaceutical Sciences·U S SharmaR M Straubinger
Jan 1, 1996·Journal of Pharmaceutical Sciences·D SongJ L Au
Nov 5, 1997·Progress in Cardiovascular Diseases·P Libby, H Tanaka
Nov 5, 1997·Progress in Cardiovascular Diseases·D P FaxonJ Currier
Jan 10, 1998·Journal of Pharmaceutical Sciences·R T LigginsH M Burt
Nov 7, 1998·Immunopharmacology and Immunotoxicology·D W MullinsK D Elgert
Aug 31, 1999·The Annals of Pharmacotherapy·B R Goldspiel
Apr 29, 2000·Circulation Research·C J CreelE R Edelman
Dec 29, 2000·Journal of the American College of Cardiology·D E DrachmanC Rogers
Jan 9, 2001·International Journal of Cancer. Journal International Du Cancer·V VerganiG Taraboletti
Feb 24, 2001·Journal of Vascular and Interventional Radiology : JVIR·P E SignoreB M McManus
Apr 28, 2001·Advanced Drug Delivery Reviews·D E Bugay
Apr 28, 2001·Advanced Drug Delivery Reviews·S R ByrnA W Newman
Jan 15, 2002·Journal of the American College of Cardiology·Harry C LoweLevon M Khachigian
Apr 20, 2002·Circulation Research·Chao-Wei Hwang, Elazer R Edelman
Jun 7, 2002·The New England Journal of Medicine·Marie-Claude MoriceUNKNOWN RAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patie
Jul 18, 2002·Journal of Vascular and Interventional Radiology : JVIR·Francesca L CellettiMichael D Dake
Sep 5, 2002·Journal of Pharmaceutical Sciences·Sarah A LorenzTroy D Wood
Oct 3, 2002·Circulation·Robert S SchwartzUNKNOWN Consensus Committee
Jan 22, 2003·Journal of the American College of Cardiology·Muzaffer DegertekinPatrick W Serruys
Mar 8, 2003·International Journal of Cardiovascular Interventions·Chao-Wei HwangElazer R Edelman
Oct 14, 2003·Drug Discovery Today·Ann W Newman, Stephen R Byrn
Apr 20, 2004·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Hartwig SteckelBernd W Müller
Jun 3, 2004·Circulation·David P FaxonUNKNOWN American Heart Association
Jun 16, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yong Woo ChoKinam Park
Jul 16, 2004·Cell Cycle·Mikhail V BlagosklonnyRobert A Herrmann
Oct 30, 2004·Journal of Biomedical Materials Research. Part a·Shrirang V RanadeMichael N Helmus
May 17, 2006·Acta Biomaterialia·Shrirang V RanadeMichael N Helmus

❮ Previous
Next ❯

Citations

Mar 5, 2009·Journal of Materials Science. Materials in Medicine·Mark BodenJames J Barry
Nov 1, 2013·Analytical Chemistry·Aaron J HarrisonLynne S Taylor
Mar 11, 2010·Biomedical Engineering Online·Barry M O'ConnellMichael T Walsh
Dec 22, 2010·AAPS PharmSciTech·Surajit Das, Anumita Chaudhury
Jan 1, 2010·Medical Devices : Evidence and Research·Juan F GranadaKeith D Dawkins
May 18, 2013·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Eric WittchowMarlen Braune
Aug 25, 2012·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Takamitsu NakamuraDongming Hou
Apr 8, 2014·Annals of Biomedical Engineering·Sujan LamichhaneGopinath Mani
Jan 8, 2014·Biomechanics and Modeling in Mechanobiology·Franz BozsakAbdul I Barakat
Dec 11, 2014·Materials Science & Engineering. C, Materials for Biological Applications·Weibin ShiMeidong Lang
Oct 22, 2011·Cellular and Molecular Life Sciences : CMLS·Paul GalvinRonan MacLoughlin
Nov 17, 2015·Expert Review of Cardiovascular Therapy·Eui Im, Myeong-Ki Hong
Feb 7, 2007·Expert Review of Medical Devices·Sabeel P ValappilIpsita Roy
Feb 26, 2009·Expert Opinion on Drug Delivery·Joanna J WykrzykowskaPatrick W Serruys
Dec 16, 2006·Endothelium : Journal of Endothelial Cell Research·Annemarie M NoordeloosP W J C Serruys
May 10, 2011·Expert Opinion on Drug Delivery·Lei LeiFei Lu
Jun 24, 2008·Endothelium : Journal of Endothelial Cell Research·H GallagherY Rochev
Aug 9, 2016·Cardiovascular Revascularization Medicine : Including Molecular Interventions·Won Yu KangNelson L Bernardo
Feb 24, 2012·Journal of Pharmaceutical Sciences·James J KleinedlerTammy R Dugas
Apr 4, 2008·Journal of Pharmaceutical Sciences·E DeconinckG Van den Mooter
May 16, 2008·Journal of Pharmaceutical Sciences·David M SaylorJames A Warren
Jan 22, 2010·Journal of Pharmaceutical Sciences·Martin K McDermottCarolyn N Witkowski
Dec 25, 2010·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Anne SeidlitzWerner Weitschies
Sep 23, 2010·Acta Biomaterialia·David M SaylorJames A Warren
Dec 5, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Rachael W SirianniW Mark Saltzman
Feb 26, 2009·International Journal of Cardiology·Tetsuo FujimakiTakeshi Hibino
Jun 20, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Anne NeubertWerner Weitschies
Jan 9, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·F UngerT Kissel
Feb 13, 2009·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Chang-Soo KimJames A Warren
Jul 1, 2014·Journal of Orthopaedic Translation·Jun MaDonghui Zhu
Apr 25, 2012·Journal of Biomedical Materials Research. Part a·Jason M OlbrichShalaby W Shalaby
Apr 9, 2013·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Martin K McDermottDinesh V Patwardhan
Apr 5, 2011·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Adam W Martinez, Elliot L Chaikof
Jul 2, 2011·IUBMB Life·Michael ChornyIvan Alferiev

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Advanced Drug Delivery Reviews
Ghanashyam Acharya, Kinam Park
The New England Journal of Medicine
Gregg W StoneTAXUS-IV Investigators
Journal of Controlled Release : Official Journal of the Controlled Release Society
Subbu Venkatraman, Freddy Boey
© 2022 Meta ULC. All rights reserved